1. Circulating Soluble CD36 is Similar in Type 1 and Type 2 Diabetes Mellitus versus Non-Diabetic Subjects
   Esmeralda Castelblanco et al, 2019, Journal of Clinical Medicine CrossRef
2. Oral fatty acid taste sensitivity in healthy young individuals of both sexes is related to body mass index and soluble cd36 serum levels
   Xochitl Trujillo et al, 2019, Nutrición Hospitalaria CrossRef
3. The Circulating Fatty Acid Transporter Soluble CD36 Is Not Associated with Carotid Atherosclerosis in Subjects with Type 1 and Type 2 Diabetes Mellitus
   Esmeralda Castelblanco et al, 2020, Journal of Clinical Medicine CrossRef
4. CD36 in chronic kidney disease: novel insights and therapeutic opportunities
   Xiaochun Yang et al, 2017, Nature Reviews Nephrology CrossRef
5. Frequency of CD36 deficiency in Thais analyzed by quantification of CD36 on cell surfaces and in plasma
   Roongaroon Phuangtham et al, 2020, Transfusion CrossRef
6. The association of soluble cluster of differentiation 36 with metabolic diseases: A potential biomarker and therapeutic target
   Yun Li et al, 2023, Pediatric Discovery CrossRef
7. Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease
   Esmeralda Castelblanco et al, 2021, Aging CrossRef
8. The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications—Update in Pathogenesis, Treatment and Monitoring
   Kamila Puchałowicz et al, 2020, Cells CrossRef
9. CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate
   Yiliang Chen et al, 2022, Journal of Experimental Medicine CrossRef
10. Lack of change in serum sCD36 concentration in children with non-alcoholic fatty liver disease – A preliminary study
    Anna Bobrus-Chociej et al, 2021, Advances in Medical Sciences CrossRef